Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Lakewood-Amedex Biotherapeutics Inc.

NASDAQ: LABT · Life Sciences · 3 alerts · CIK 2079272

Share price
$0.2194Close, Nov 16
Market cap
$520K
Shares outstanding
2.37MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Lakewood-Amedex Biotherapeutics Inc. filings on SEC EDGAR ↗

4:41 PM ET 8-K
Nasdaq/NYSE Compliance Notice

Lakewood-Amedex Biotherapeutics Nasdaq/NYSE Compliance Notice

Lakewood-Amedex Biotherapeutics received a delisting notice from Nasdaq on November 10, 2026, because its common stock failed to maintain the $1.00 minimum bid price for 30 consecutive business days. Due to a prior reverse stock split within the last year, the company is ineligible for a standard compliance period and faces immediate suspension unless it successfully appeals to a Nasdaq Hearings Panel. The company intends to request a hearing to stay the delisting and present a plan to regain compliance.

Counterparty
The Nasdaq Stock Market LLC
5:21 PM ET 8-K
Other 8-K Filing

Lakewood-Amedex Biotherapeutics Other 8-K Filing

Lakewood-Amedex Biotherapeutics entered into a Share Redemption Agreement to redeem all 127,097 outstanding shares of its Series C Convertible Preferred Stock for $1.27 million in cash. The transaction simplifies the company's capital structure, eliminates potential dilution from future conversions, and removes associated financing restrictions.

Counterparty
Shakawe Capital LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.